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LETTERS TO THE EDITOR
Reverse epidemiology and
obesity in maintenance
dialysis patients
To the Editor: I was quite interested to read the recent
article by Kalantar-Zadeh et al [1]. The authors cite sev-
eral studies [2] to support a uniform effect of obesity
on survival. However, there have been some American
studies that show the effect of obesity on survival in
chronic dialysis patients is far from uniform. First, Kutner
and Zhang [3] showed in a statewide cohort that the appar-
ent benefit of obesity in chronic hemodialysis patients did
not apply to white females. This finding was confirmed
by our institution in a report by Glanton et al [4], which
looked at over 151,027 chronic dialysis patients from 1995
to 1997. Even more intriguing, we found that the only
specific cause of death that was significantly more common
among obese women was death due to infection, predomi-
nantly vascular access infection and extremity gangrene.
Therefore, “reverse epidemiology” notwithstanding, we
believe this represents an opportunity to improve the
health of patients on chronic dialysis. Perhaps most intri-
guing of all, however, is Glanton et al’s [5] most recent
paper, which showed that obese patients on the renal
transplant waiting list still had a survival benefit after renal
transplantation compared to remaining on dialysis. We
believe similar approaches may successfully lead to “a
reversal of the reverse epidemiology and a return to tradi-
tional epidemiology,” as the authors stated.
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Reply from the Authors
We appreciate the important points made by Dr. Ab-
bott in his Letter to the Editor. We, indeed, reiterated
that the relationship between an increased weight and a
better clinical outcome in dialysis patients is not com-
pletely uniform [1]. For example, as we mentioned in our
review [1], in Asian American hemodialysis patients, a
conventional (and not a reverse epidemiology) pattern
has been shown (i.e., obese Asian American dialysis pa-
tients have a worse clinical outcome) [2]. However, the
general trend in almost all epidemiological studies of main-
tenance hemodialysis patients has been consistent with the
reverse epidemiology, even though exceptional subpopula-
tions are occasionally described. Glanton et al [3] indicated
that obesity was associated with increased risk of infectious
death in female dialysis patients; however, the same study
found that in all other dialysis patients, and especially
among African Americans, obesity was indeed associ-
ated independently with reduced all-cause mortality. In
the study by Kutner and Zhang [4], only white females
did not show the reverse epidemiology pattern, whereas
black female, black male, and white male hemodialysis
patients with higher body mass index had a reduced risk
of mortality. The reverse epidemiology is a new concept
that should be further examined and modified, as neces-
sary, to accommodate such exceptional subpopulations.
Identifying non–end-stage renal disease groups with a
reverse epidemiology, such as individuals with heart fail-
ure, metastatic cancer, acquired immunodeficiency syn-
drome, or advanced age may promote better understand-
ing of the mechanisms involved in the reversal of the
effect of conventional risk factors in such populations, as
well as among end-stage renal disease patients [abstract;
Kalantar-Zadeh K et al, Am J Kidney Dis, 2003].
Kamyar Kalantar-Zadeh, Gladys Block,
Michael H. Humphreys, Joel D. Kopple
Torrance, California
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